You just read:

OxThera Receives Positive Decision From EMA on Paediatric Investigational Plan (PIP) for Treatment of Primary Hyperoxaluria With Oxalobacter formigenes

News provided by

OxThera AB

23 Aug, 2019, 09:00 BST